STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
134
13F, latest reported quarter
What the filings say about PHR
Insiders, 180 days
-$128.8K net sold
1 buyer · 3 sellers · 17% of sales under a 10b5-1 plan
Congress, 1 year
0 bought · 2 sold
Latest: sale, 2026-08-26
Planned sales (Form 144), 90 days
$67.2K
1 notice
Phreesia insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Phreesia, Inc. insiders sold a net $128.8K of stock across 414 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
48 earlier Form 4 trades (code P or S) here by this insider (48 sales), the last on Apr 20, 2026.
The trade is 2.5% of the 266,574 shares held after it.
No other insider sold within 30 days.
134 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: General Counsel & Secretary Hoffman Allison C sold about $67.2K of PHR under a 10b5-1 plan on Sep 21, 2026; 134 funds added in the latest 13F quarter.
33 earlier Form 4 trades (code P or S) here by this insider (33 sales), the last on Jul 6, 2026.
The trade is 5.7% of the 21,724 shares held after it.
1 other insider sold within 30 days.
134 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Principal Accounting Officer Hui Yvonne sold about $13.6K of PHR on Jul 16, 2026; 1 other insider sold within 30 days and 134 funds added in the latest 13F quarter.
4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on Jun 25, 2026.
The trade is 1.4% of the 37,780 shares held after it.
1 other insider sold within 30 days.
134 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Egbuonu-Davis Lisa sold about $5.7K of PHR on Jul 14, 2026; 1 other insider sold within 30 days and 134 funds added in the latest 13F quarter.
414 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Cambiar SMID Fund
$691.0K position · as of 2026-07-31
1.8%
Cambiar Small Cap Fund
$1.2M position · as of 2026-07-31
1.8%
State Street(R) SPDR(R) FactSet Innovative Technology ETF
$413.4K position · as of 2026-06-30
0.6%
Columbia Integrated Small Cap Growth Fund
$192.5K position · as of 2026-05-31
0.6%
AVE MARIA WORLD EQUITY FUND
$809.8K position · as of 2026-06-30
0.5%
VictoryShares Small Cap Free Cash Flow ETF
$2.8M position · as of 2026-06-30
0.5%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Mr. Indig
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$8.1M
-$17.9M
$3.4M
-79%
+61%
2024
$10.5M
$11.8M
$4.1M
-8%
+109%
2023
$8.3M
-$240.0K
$4.3M
-18%
+88%
2022
$7.6M
$12.5M
$3.7M
+21%
+27%
2021
$8.9M
-$15.0M
$3.7M
+1%
+50%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $128.8K sold by insiders over 180 days, 134 funds added last quarter, $67.2K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$507.8M
four quarters, 2025-08-01 to 2026-07-31
Revenue, TTM PHR
FY Jan 2026
$480.6M
FY Jan 2025
$419.8M
FY Jan 2024
$356.3M
FY Jan 2023
$280.9M
FY Jan 2022
$213.2M
Jul 2026
$129.5M
Apr 2026
$130.9M
Jan 2026
$127.1M
Oct 2025
$120.3M
Jul 2025
$117.3M
Apr 2025
$115.9M
Jan 2025
$109.7M
Oct 2024
$106.8M
At each fiscal year end
Single quarter
Net margin, TTM
+2.1%
net income over revenue, 2025-08-01 to 2026-07-31
Net margin, TTM PHR
FY Jan 2026
+0.5%
FY Jan 2025
-13.9%
FY Jan 2024
-38.4%
FY Jan 2023
-62.7%
FY Jan 2022
-55.4%
Jul 2026
+1.5%
Apr 2026
+2.3%
Jan 2026
+1.0%
Oct 2025
+3.5%
Jul 2025
+0.6%
Apr 2025
-3.4%
Jan 2025
-5.8%
Oct 2024
-13.5%
At each fiscal year end
Single quarter
Free cash flow, TTM
$80.7M
operating cash flow minus capex, 2025-08-01 to 2026-07-31
Free cash flow, TTM PHR
FY Jan 2026
$67.7M
FY Jan 2025
$23.7M
FY Jan 2024
-$38.2M
FY Jan 2023
-$94.9M
FY Jan 2022
-$93.1M
Jul 2026
$17.8M
Apr 2026
$19.6M
Jan 2026
$31.1M
Oct 2025
$12.2M
Jul 2025
$13.1M
Apr 2025
$11.3M
Jan 2025
$13.5M
Oct 2024
$5.2M
At each fiscal year end
Single quarter
Debt to equity
0.00x
LongTermDebt as filed 2026-07-31 (includes the current portion); equity 2026-07-31
Debt to equity PHR
FY Jan 2026
0.01x
FY Jan 2025
0.01x
FY Jan 2024
0.01x
FY Jan 2023
0.00x
FY Jan 2022
0.00x
Jul 2026
0.00x
Apr 2026
0.00x
Jan 2026
0.01x
Oct 2025
0.00x
Jul 2025
0.00x
Apr 2025
0.01x
Jan 2025
0.01x
Oct 2024
0.01x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
80.02x
TTM operating cash flow over LongTermDebt as filed 2026-07-31 (includes the current portion)
Cash flow to debt PHR
FY Jan 2026
29.66x
FY Jan 2025
16.72x
FY Jan 2024
-10.29x
FY Jan 2023
-366.35x
FY Jan 2022
-207.53x
Jul 2026
80.02x
Apr 2026
143.60x
Jan 2026
29.66x
Oct 2025
63.70x
Jul 2025
39.76x
Apr 2025
29.44x
Jan 2025
16.72x
Oct 2024
5.63x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+3.1%
TTM net income over average of 2025-07-31 and 2026-07-31
Return on equity PHR
FY Jan 2026
+0.8%
FY Jan 2025
-22.7%
FY Jan 2024
-50.8%
FY Jan 2023
-50.0%
FY Jan 2022
-34.7%
Jul 2026
+3.1%
Apr 2026
+2.9%
Jan 2026
+0.8%
Oct 2025
-1.9%
Jul 2025
-8.8%
Apr 2025
-16.0%
Jan 2025
-22.7%
Oct 2024
-31.9%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+2.0%
TTM net income over average of 2025-07-31 and 2026-07-31
Return on assets PHR
FY Jan 2026
+0.4%
FY Jan 2025
-15.4%
FY Jan 2024
-37.0%
FY Jan 2023
-40.7%
FY Jan 2022
-28.8%
Jul 2026
+2.0%
Apr 2026
+1.7%
Jan 2026
+0.4%
Oct 2025
-1.3%
Jul 2025
-6.2%
Apr 2025
-11.1%
Jan 2025
-15.4%
Oct 2024
-22.1%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
effective tax rate -278%, not meaningful
Return on invested capital PHR
FY Jan 2026
n/a
FY Jan 2025
n/a
FY Jan 2024
n/a
FY Jan 2023
n/a
FY Jan 2022
n/a
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Jan 2025
n/a
Oct 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+3.1%
operating income (EBIT proxy) over average of 2025-07-31 and 2026-07-31 minus current liabilities
Return on capital employed PHR
FY Jan 2026
-1.8%
FY Jan 2025
-21.7%
FY Jan 2024
-49.5%
FY Jan 2023
-49.2%
FY Jan 2022
-33.5%
Jul 2026
+3.1%
Apr 2026
+0.9%
Jan 2026
-1.8%
Oct 2025
-2.9%
Jul 2025
-9.3%
Apr 2025
-15.2%
Jan 2025
-21.7%
Oct 2024
-29.5%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
74.71x
close 2026-10-23 over four quarters of diluted EPS, 2025-08-01 to 2026-07-31
P/E, trailing PHR
FY Jan 2026
447.67x
FY Jan 2025
n/a
FY Jan 2024
n/a
FY Jan 2023
n/a
FY Jan 2022
n/a
Jul 2026
63.12x
Apr 2026
61.40x
Jan 2026
447.67x
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Jan 2025
n/a
Oct 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$715.6M
market value at close 2026-10-23 on 2026-08-27 shares, plus LongTermDebt as filed 2026-07-31 (includes the current portion), minus cash 2026-01-31
Enterprise value PHR
FY Jan 2026
$738.5M
FY Jan 2025
$1.6B
FY Jan 2024
$1.3B
FY Jan 2023
$1.8B
FY Jan 2022
$1.3B
Jul 2026
$590.6M
Apr 2026
$486.4M
Jan 2026
$738.5M
Oct 2025
$1.3B
Jul 2025
$1.5B
Apr 2025
$1.4B
Jan 2025
$1.6B
Oct 2024
$977.3M
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+10.2%
TTM free cash flow over market value at close 2026-10-23
FCF yield PHR
FY Jan 2026
+8.4%
FY Jan 2025
+1.4%
FY Jan 2024
-2.7%
FY Jan 2023
-4.8%
FY Jan 2022
-5.8%
Jul 2026
+12.2%
Apr 2026
+13.6%
Jan 2026
+8.4%
Oct 2025
+3.7%
Jul 2025
+2.7%
Apr 2025
+2.5%
Jan 2025
+1.4%
Oct 2024
+0.4%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
prior-year trailing EPS was a loss, growth undefined
PEG, trailing PHR
FY Jan 2026
n/a
FY Jan 2025
n/a
FY Jan 2024
n/a
FY Jan 2023
n/a
FY Jan 2022
n/a
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Jan 2025
n/a
Oct 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
PHR ranks highest on financial health (94th percentile) and growth (68th), and lowest on risk and compliance (28th), among Services peers.
Profitability
47
Inputs
Return on equity+3.1% · 43 pct, sector of 207
Return on assets+2.0% · 54 pct, sector of 269
Return on invested capitaleffective tax rate -278%, not meaningful
Return on capital employed+3.1% · 45 pct, sector of 203
Financial health
94
Inputs
Debt to equity0.00x · 89 pct, sector of 228
Cash flow to debt80.02x · 99 pct, sector of 199
Growth
68
Inputs
Revenue growth, YoY+14.0% · 68 pct, sector of 341
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
61
Inputs
Net Form 4 buying (codes P and S), 180d-$62K · 65 pct, sector of 174
Insider buyers, 180d1 · 57 pct, sector of 179
Institutional and government
30
Inputs
Funds adding, latest quarter134 · 58 pct, sector of 243
Congress net buyers, 365d-2 · 6 pct, sector of 37
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quarters$240K · 27 pct, sector of 61
Risk and compliance
28
Inputs
Short interest, % of float+6.1% · 30 pct, sector of 383
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+17.2% · 27 pct, sector of 227
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
PHR filings, in plain words
Are Phreesia insiders buying or selling PHR?
In the 180 days to 2026-10-27, Phreesia insiders were net sellers, a net $128.8K: $682 of purchases and $129.4K of sales reported on Form 4, by 1 buyer and 3 sellers.
Have members of Congress traded PHR?
Yes. In the year to 2026-10-27, 0 House members disclosed buying PHR and 2 House members disclosed selling it; the latest on record is a sale by Gilbert Cisneros dated 2026-08-26.
Are there planned insider sales of PHR?
Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-27, covering $67.2K of stock; the latest, by Hoffman Allison C, was filed 2026-09-21.
Read the full summary
In the 180 days to 2026-10-27, Phreesia insiders were net sellers of PHR, a net $128.8K across purchases and sales reported on Form 4 by 1 buyer and 3 sellers. Sales outweighed purchases more than tenfold by value. 17% of the 6 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. In the year to 2026-10-27, 0 members of Congress disclosed buying PHR and 2 members disclosed selling it; the latest on record is a sale by Gilbert Cisneros dated 2026-08-26. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-27, covering $67.2K of stock. The latest 5% ownership filing is a 13D by Pale Fire Capital SICAV a.s., filed 2026-02-19, for 9.2% of the class. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.